BAY 41-2272

Code: 196876-5MG D2-231

Biochem/physiol Actions

Reversible: no

Product does not compete with ATP.

Target IC50: 304 nM inhibiting phenylephrine-induced constriction of rabbit a...


 Read more

Your Price
€260.58 EACH
€320.51 inc. VAT

Biochem/physiol Actions

Reversible: no

Product does not compete with ATP.

Target IC50: 304 nM inhibiting phenylephrine-induced constriction of rabbit aortic rings; 36 nM in blocking collagen-induced aggregation of human platelets

Cell permeable: yes

Primary TargetSoluble guanylate cyclase

General description

A cell-permeable pyrazolopyridinylpyrimidine compound that acts as a selective and potent stimulator of soluble guanylate cyclase (effective dose ~ 0.1 nM to 100 µM using recombinant soluble guanylate cyclase). The mode of activation is NO-independent and appears to be mediated through direct binding to the A1 and A2 subunits. Shown to be effective in treating numerous cardiovascular conditions in animal models. Inhibits phenylephrine-induced constriction of rabbit aortic rings (IC50 = 304 nM) and blocks collagen-induced aggregation of human platelets (IC50 = 36 nM). Does not inhibit phosphodiesterases.

A cell-permeable pyrazolopyridinylpyrimidine compound that acts as a selective and potent stimulator of soluble guanylate cyclase (effective dose ~0.1 nM to 100 µM using recombinant soluble guanylate cyclase). The mode of activation is NO-independent and appears to be mediated through direct binding to the A1 and A2 subunits. Shown to be effective in treating numerous cardiovascular conditions in animal models. Inhibits phenylephrine-induced constriction of rabbit aortic rings (IC50 = 304 nM) and blocks collagen-induced aggregation of human platelets (IC50 = 36 nM). Does not inhibit phosphodiesterases.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Boerrigter, G., et al. 2003. Circulation107, 686.Kalsi, J.S., et al. 2003. J Urol.169, 761.Koglin, M., et al. 2002. Biochem. Biophys. Res. Commun.292, 1057.Becker, E.M., et al. 2001. BMC Pharmacol.1, 13.Stasch, J.P., et al. 2001. Nature410, 212.

Packaging

5 mg in Plastic ampoule

Reconstitution

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.

Warning

Toxicity: Standard Handling (A)

assay≥98% (HPLC)
colorwhite
formsolid
manufacturer/tradenameCalbiochem®
Quality Level100
shipped inambient
solubilityDMSO: 10 mg/mL
storage conditionprotect from light, OK to freeze
storage temp.2-8°C
Cas Number256376-24-6
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.